ClinicalTrials.Veeva

Menu
N

Nashville Neuroscience Group | Bryant Research Group

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Atogepant
ABP-450
Erenumab
Sumatriptan
AMG334
LY2951742
Rimegepant
NXN-462
AGN-241689
Lasmiditan

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 18 total trials

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and so...

Active, not recruiting
Episodic Migraine
Drug: Placebo
Drug: BOTOX
Locations recently updated

Migraine is characterized by attacks of throbbing, moderate or severe headache, often associated with nausea, vomiting, and/or sensitivity to light a...

Enrolling
Chronic Migraine
Drug: Atogepant

Trial sponsors

Amgen logo
A
AbbVie logo
Allergan logo
Lilly logo
Boston Scientific logo
N
N
Pfizer logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems